Inactive Instrument
Phosphagenics Limited Stock Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 88.87M 63.64M 54.8M 51.45M 46.97M 88.23M 6.06B 610M 237M 3.07B 239M 234M 10.17B | P/E 2024 |
-2.5x | P/E 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 84.22M 60.31M 51.93M 48.76M 44.51M 83.62M 5.74B 578M 225M 2.91B 226M 222M 9.64B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
76.76% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 01/05/2020 |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | 28/12/2018 |
Roksan Libinaki
COO | Chief Operating Officer | - | 01/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 13/04/2015 |
Gregory Collier
CHM | Chairman | - | 01/01/2019 |
Kathy Connell
BRD | Director/Board Member | 59 | 26/04/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 63.64M | ||
| -1.52% | -7.23% | +57.90% | +108.72% | 1,031B | ||
| -0.82% | -2.63% | +50.05% | +64.43% | 641B | ||
| +0.37% | -3.06% | +21.87% | +74.48% | 453B | ||
| -1.64% | -4.75% | +35.59% | +35.54% | 349B | ||
| -0.39% | -2.76% | +21.39% | +38.01% | 290B | ||
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | ||
| -0.59% | -3.15% | +49.83% | +67.70% | 232B | ||
| -1.05% | -2.29% | -19.91% | -54.10% | 201B | ||
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | ||
| Average | -2.07% | -2.98% | +27.56% | +48.63% | 403.31B | |
| Weighted average by Cap. | -0.88% | -3.97% | +36.82% | +64.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 811K 698K 656K 599K 1.12M 77.18M 7.77M 3.02M 39.14M 3.05M 2.98M 130M | 1.24M 886K 763K 717K 654K 1.23M 84.35M 8.49M 3.3M 42.77M 3.33M 3.26M 142M |
| Net income | -3.12M -2.24M -1.93M -1.81M -1.65M -3.1M -213M -21.42M -8.33M -108M -8.4M -8.21M -357M | -4.42M -3.16M -2.72M -2.56M -2.33M -4.39M -301M -30.3M -11.79M -153M -11.88M -11.62M -505M |
| Net Debt | -1.3M -930K -800K -751K -686K -1.29M -88.44M -8.9M -3.46M -44.85M -3.49M -3.41M -148M | -4.65M -3.33M -2.87M -2.69M -2.46M -4.62M -317M -31.9M -12.41M -161M -12.5M -12.23M -532M |
Employees
-
Sector
Pharmaceuticals
















